Distribution of drugs over whole blood: I. The transport function of whole blood for valproate.
A method is presented for the determination of valproate (VPA) in approximately 40 microliters erythrocyte concentrations. Valproate partition between plasma proteins, ultrafiltrate, and erythrocytes at various concentrations was studied in vitro and in vivo. Partition ratios depended on VPA concentration in whole blood and the ratio of erythrocytes/ultrafiltrate, which increased with rising concentrations in the ultrafiltrate fraction. Shifts in ratios were studied by expanding the ultrafiltrate fraction of VPA-spiked blood. It appeared that VPA delivery to the expanded ultrafiltrate compartment originated in a disproportionately large part from erythrocytes. In vivo the half-life of VPA in the erythrocyte fraction was 0.7 h, whereas in the ultrafiltrate fraction and protein-bound fraction half-lives of 2 and 5 h were observed. It is concluded that for VPA in relation to erythrocytes a "last-come-first-go" system is plausible.
Driessen
O
O
Department of Pharmacology, Sylvius Laboratories, Leiden, The Netherlands.
Treuren
L
L
Meijer
J W
JW
D001798:Blood Proteins / Q000378:metabolism; D001834:Body Water / Q000378:metabolism; D002849:Chromatography, Gas; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D011485:Protein Binding; D014462:Ultrafiltration; D014635:Valproic Acid / Q000097:blood* / Q000493:pharmacokinetics
D001798:Blood Proteins; D014635:Valproic Acid